CMR Surgical

CMR Surgical is a Cambridge, U.K.-based surgical robotics company. In 2014, its 5 founders asked why many people were still not getting minimal access surgery and how this could be changed; from there CMR grew into a global business headquartered in Cambridge UK. The company develops the Versius Surgical Robotic System, which has been used to treat more than 45,000 patients worldwide and adopted in hospitals across more than 30 countries. Its next-generation Versius Plus system received FDA 510(k) clearance for cholecystectomy, and a 510(k) submission has been filed for benign gynecologic indications.

In 2014, CMR Surgical's 5 founders asked why many people were still not getting minimal access surgery and how this could be changed. From there CMR grew into a global business headquartered in Cambridge UK. Versius has been adopted in hospitals across more than 30 countries, supporting procedures including general surgery, colorectal surgery, and urology. More than 45,000 patients worldwide have been treated using the Versius Surgical Robotic System. CMR is launching Versius in the U.S. following FDA clearance of the next-generation Versius Plus system in December 2025 for cholecystectomy (gallbladder removal).

• Versius Surgical Robotic System

  A surgical robotic system used to treat more than 45,000 patients worldwide and adopted in hospitals across more than 30 countries.

• Versius Plus

  The next generation in surgical robotics, developed and engineered for versatility and adaptability, driven by a digital ecosystem embedded at its core. FDA 510(k) cleared for Cholecystectomy; 510(k) submission filed for benign gynecologic indications.

• 2026-10-12

  Stryker makes $400 million strategic investment in CMR Surgical[5]Stryker 斥资 4 亿美元策略性投资 CMR Surgicaln.yam.com

  Reported: 2026-10-13

  Stryker announced on Monday (2026-10-12) that it has established a partnership with soft tissue robotics company CMR Surgical and made a strategic investment of about US$400 million (about NT$12.9 billion), marking Stryker's formal entry into soft tissue robotic surgery. The agreement also grants Stryker an exclusive option to acquire CMR Surgical's remaining shares in the future.

  Weekdays and relative dates follow the original report; their exact calendar dates have not been verified.

• 2026-10-12

  Stryker to become exclusive US distributor of CMR Surgical's Versius robot system[5]Stryker 斥资 4 亿美元策略性投资 CMR Surgicaln.yam.com

  Reported: 2026-10-13

  Under the agreement announced on Monday (2026-10-12), Stryker will become the exclusive US distributor of CMR Surgical's Versius robotic system, while CMR Surgical continues to lead its commercial operations in other global markets.

  Weekdays and relative dates follow the original report; their exact calendar dates have not been verified.

• 2021-06-28

  CMR Surgical raises $600 million in Series D financing[6]CMR Surgical完成6亿美元D轮融资finance.yahoo.com

  Reported: 2021-06-28

  CMR Surgical announced that it raised $600 million in Series D financing. The company said the funds would support global commercialisation of its Versius surgical robotic system and further development of its digital ecosystem.

• 2020-06-23

  CMR Surgical appoints Barrington D'Arcy as chief operations officer[7]CMR Surgical 任命 Barrington D'Arcy 为首席运营官finanznachrichten.de

  Reported: 2020-06-23

  CMR Surgical announced Barrington D'Arcy's appointment as chief operations officer. He will oversee the company's manufacturing and supply chain to support its global expansion.

1. 1CMR Surgical - Transforming Surgery. For Good.us.cmrsurgical.com
2. 2About Us | CMR Surgical - CMR Surgicalus.cmrsurgical.com
3. 3Company Polices I CMR Surgical - CMR Surgicalus.cmrsurgical.com
4. 4CMR Surgical Announces 45k Patients Treated Globally - CMR Surgicalus.cmrsurgical.com
5. 5Stryker 斥资 4 亿美元策略性投资 CMR Surgicaln.yam.com
6. 6CMR Surgical完成6亿美元D轮融资finance.yahoo.com
7. 7CMR Surgical 任命 Barrington D'Arcy 为首席运营官finanznachrichten.de